Log In
Print
BCIQ
Print
Print this Print this
 

CX-5461

  Manage Alerts
Collapse Summary General Information
Company Senhwa Biosciences Inc.
DescriptionOral RNA polymerase I (Pol-I) inhibitor activating the p53 pathway
Molecular Target RNA polymerase I (Pol I) ; p53
Mechanism of ActionRNA polymerase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today